Clinical Psychedelic Research Lab

Welcome to
The Clinical Psychedelic Research Lab

The Clinical Psychedelic Research Lab is establishing a rigorous program of research in psychedelic medicine at Monash University that seeks to evaluate therapeutic effects, innovate on treatment design, mitigate known risks, explore potential drawbacks, and understand therapeutic mechanisms.

The Lab is led by Dr Paul Liknaitzky.

The Lab is part of the School of Psychological Sciences within the Turner Institute for Brain and Mental Health, and the Department of Psychiatry within the School of Clinical Sciences.

Latest announcement - Expressions of interest now open: psilocybin-assisted therapy training and work

25th June 2021: The Clinical Psychedelic Lab is now inviting expressions of interest from mental healthcare professionals who would like to train and work as therapists on the Psi-GAD-1 trial at Monash University, exploring the use of psilocybin-assisted psychotherapy in the treatment of Generalised Anxiety Disorder. To apply, you must be based in Melbourne, Australia. Training commences in August. If interested, please email us at psychedelic@monash.edu and request further information.
Find out more.